Update: non-invasive ventilation in chronic obstructive pulmonary disease.

Area of Science:

• Pulmonology
• Critical Care Medicine

Background:

• Chronic obstructive pulmonary disease (COPD) is a major global health burden, associated with significant morbidity and mortality.
• Respiratory failure, both acute and chronic, worsens prognosis in COPD patients.
• Non-invasive ventilation (NIV) is a recognized therapeutic modality in acute and chronic care settings for respiratory compromise.

Purpose of the Study:

• To review the established and emerging roles of non-invasive ventilation (NIV) in managing patients with chronic obstructive pulmonary disease (COPD).
• To evaluate the efficacy of NIV in acute exacerbations and chronic respiratory failure.
• To discuss alternative and adjunctive therapies like high-flow humidified therapy.

Main Methods:

• Literature review of clinical studies and guidelines on NIV use in COPD.
• Analysis of data regarding mortality, intubation rates, and symptom palliation.
• Examination of evidence for NIV in acute decompensated respiratory failure and chronic hypercapnic respiratory failure.

Main Results:

• NIV is the gold standard for acute decompensated respiratory failure in COPD, significantly reducing mortality and intubation.
• NIV is increasingly utilized for weaning from invasive ventilation and palliative care.
• Recent data suggest a beneficial role for NIV in selected subgroups of patients with chronic hypercapnic respiratory failure.

Conclusions:

• NIV is a critical intervention for acute COPD exacerbations with respiratory failure.
• The application of NIV in chronic hypercapnic respiratory failure is expanding, with evidence supporting its use in specific patient populations.
• High-flow humidified therapy presents a potential alternative or adjunct to NIV in certain clinical scenarios.